Diadema Partners’s scPharmaceuticals SCPH Stock Holding History

Diadema Partners’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-462,000	Closed	-$2.62M	–	190
2025 Q3	$2.62M	Sell	462,000 -24,500	-5%	-$125K	0.67%	50
2025 Q2	$1.85M	Buy	+486,500	New	+$1.51M	0.56%	47

Diadema Partners's SCPH Position: Q3 2025 in Review

Diadema Partners sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 217,623 shares — an estimated $1.11M sold.

Diadema Partners first reported a position in SCPH in Q2 2025 and held it in 1 quarter. The position peaked at $829K in Q2 2025. 109 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Diadema Partners reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
Diadema Partners sold 217,623 scPharmaceuticals shares in Q3 2025, an estimated $1.11M.
Diadema Partners first reported a position in scPharmaceuticals in Q2 2025 and held it in 1 quarter.
Diadema Partners's scPharmaceuticals position peaked at $829K in Q2 2025.
109 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Diadema Partners's 13F filing for Q3 2025, filed 14 Nov 2025.